dc.creator | Smilevska, T. | en |
dc.creator | Stamatopoulos, K. | en |
dc.creator | Samara, M. | en |
dc.creator | Belessi, C. | en |
dc.creator | Tsompanakou, A. | en |
dc.creator | Paterakis, G. | en |
dc.creator | Stavroyianni, N. | en |
dc.creator | Athanasiadou, I. | en |
dc.creator | Chiotoglou, I. | en |
dc.creator | Hadzidimitriou, A. | en |
dc.creator | Athanasiadou, A. | en |
dc.creator | Douka, V. | en |
dc.creator | Saloum, R. | en |
dc.creator | Laoutaris, N. | en |
dc.creator | Anagnostopoulos, A. | en |
dc.creator | Fassas, A. | en |
dc.creator | Stathakis, N. | en |
dc.creator | Kollia, P. | en |
dc.date.accessioned | 2015-11-23T10:47:32Z | |
dc.date.available | 2015-11-23T10:47:32Z | |
dc.date.issued | 2006 | |
dc.identifier | 10.1016/j.leukres.2005.06.006 | |
dc.identifier.issn | 1452126 | |
dc.identifier.uri | http://hdl.handle.net/11615/33100 | |
dc.description.abstract | Transferrin receptor (TfR)-1 and 2 mRNA and CD71 (TfR1) expression was analyzed in 118 CLL patients. Ninety-five out of 109 analyzed cases expressed CD71, mostly at a high level; 60% of CD71 (+) cases were IGH-mutated. All samples were TfR1 mRNA (+); TfR2-alpha/beta mRNA was detected in, respectively, 52/102 and 100/109 cases. Competitive RT-PCR showed widely divergent levels of TfR1 mRNA in cases with high CD71 expression, alluding to postrtanscriptional control of TfR1 expression in CLL. The almost uniformly high CD71 expression in CLL is in keeping with the activated status of neoplastic cells, regardless of IGH mutational load. © 2005 Elsevier Ltd. All rights reserved. | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-28844495516&partnerID=40&md5=def3f6714e4660463557263d35da6090 | |
dc.subject | B cells | en |
dc.subject | Chronic lymphocytic leukemia | en |
dc.subject | IG genes | en |
dc.subject | Iron | en |
dc.subject | Transferrin receptor | en |
dc.subject | CD71 antigen | en |
dc.subject | messenger RNA | en |
dc.subject | receptor subunit | en |
dc.subject | transferrin receptor 2alpha | en |
dc.subject | transferrin receptor 2beta | en |
dc.subject | unclassified drug | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | article | en |
dc.subject | chronic lymphatic leukemia | en |
dc.subject | controlled study | en |
dc.subject | female | en |
dc.subject | gene expression | en |
dc.subject | gene sequence | en |
dc.subject | human | en |
dc.subject | human tissue | en |
dc.subject | male | en |
dc.subject | mutagenesis | en |
dc.subject | priority journal | en |
dc.subject | protein determination | en |
dc.subject | protein expression | en |
dc.subject | protein function | en |
dc.subject | receptor density | en |
dc.subject | receptor intrinsic activity | en |
dc.subject | reverse transcription polymerase chain reaction | en |
dc.subject | transcription regulation | en |
dc.subject | tumor cell | en |
dc.subject | Antigens, CD | en |
dc.subject | Antigens, CD38 | en |
dc.subject | Antigens, Differentiation, T-Lymphocyte | en |
dc.subject | Humans | en |
dc.subject | Immunoglobulin Heavy Chains | en |
dc.subject | Immunophenotyping | en |
dc.subject | Leukemia, Lymphocytic, Chronic | en |
dc.subject | Middle Aged | en |
dc.subject | Mutation | en |
dc.subject | Receptors, Transferrin | en |
dc.subject | RNA, Messenger | en |
dc.title | Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia | en |
dc.type | journalArticle | en |